RTW Investments, LP 13D and 13G filings for Rocket Pharmaceuticals, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-12-16 7:51 pm Purchase |
2024-12-12 | 13D | Rocket Pharmaceuticals, Inc. RCKT |
RTW Investments, LP | 18,401,313 17.600% |
212,856 (+1.17%) |
Filing |
| 2023-09-19 4:15 pm Unchanged |
2023-09-15 | 13D | Rocket Pharmaceuticals, Inc. RCKT |
RTW Investments, LP | 18,188,457 20.320% |
0 (Unchanged) |
Filing |
| 2023-04-05 4:31 pm Purchase |
2022-12-01 | 13D | Rocket Pharmaceuticals, Inc. RCKT |
RTW Investments, LP | 18,188,457 23.000% |
559,890 (+3.18%) |
Filing |
| 2022-10-11 4:30 pm Purchase |
2022-10-06 | 13D | Rocket Pharmaceuticals, Inc. RCKT |
RTW Investments, LP | 17,628,567 24.400% |
1,355,932 (+8.33%) |
Filing |
| 2022-09-21 09:00 am Unchanged |
2022-09-19 | 13D | Rocket Pharmaceuticals, Inc. RCKT |
RTW Investments, LP | 16,272,635 24.600% |
0 (Unchanged) |
Filing |
| 2021-08-31 5:08 pm Purchase |
2021-05-11 | 13D | Rocket Pharmaceuticals, Inc. RCKT |
RTW Investments, LP | 16,272,635 25.300% |
87,516 (+0.54%) |
Filing |
| 2021-03-29 5:19 pm Sale |
2021-03-24 | 13D | Rocket Pharmaceuticals, Inc. RCKT |
RTW Investments, LP | 16,185,119 26.200% |
-1,344,925 (-7.67%) |
Filing |
| 2021-01-08 3:30 pm Purchase |
2020-12-10 | 13D | Rocket Pharmaceuticals, Inc. RCKT |
RTW Investments, LP | 17,530,044 29.300% |
247,720 (+1.43%) |
Filing |